In a phase 3 trial, the Breast Cancer Locator was noninferior to wire localization and lowered positive margin rates in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results